All In Biotech

Drug Trial Radar · NCT06662383

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity

Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Nov 1, 2024

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Oct 28, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity. The study will last about 89 weeks.

Conditions

  • Obesity

Interventions

  • RetatrutideDrug

    Administered SC

  • TirzepatideDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Body WeightTime frame: Baseline, Week 80

Locations

65 sites in 5 countries. Site status is shown where the registry gives one.

  • Medical Advancement Centers of Arizona

    Tempe, Arizona

  • Mary & Dick Allen Diabetes Center

    Newport Beach, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Encompass Clinical Research

    Spring Valley, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Lynn Institute of Denver

    Aurora, Colorado

  • Bridgeport Hospital

    Bridgeport, Connecticut

  • Yale University School of Medicine

    New Haven, Connecticut

  • Encore Medical Research

    Hollywood, Florida

  • Suncoast Research Group

    Miami, Florida

  • Onhealth Research Center

    Miami, Florida

  • Precision Clinical Research

    Sunrise, Florida

  • Einstein Clinical Research

    Vero Beach, Florida

  • ClinCept Clinical Research - MH

    Columbus, Georgia

  • Northeast Georgia Medical Center

    Gainesville, Georgia

  • Pivotal Research Solutions

    Stonecrest, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Northwestern University

    Chicago, Illinois

  • Integrated Clinical Trial Services, Inc.

    West Des Moines, Iowa

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Great Lakes Research Group, Inc.

    Bay City, Michigan

  • Great Lakes Research Institute

    Southfield, Michigan

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Las Vegas Endocrinology

    Henderson, Nevada

  • Albany Medical College, Division of Community Endocrinology

    Albany, New York

  • New York Gastroenterology Associates

    New York, New York

  • Westchester Medical Center

    Valhalla, New York

  • PharmQuest Life Sciences, LLC

    Greensboro, North Carolina

  • Monroe Biomedical Research

    Monroe, North Carolina

  • Accellacare - Wilmington

    Wilmington, North Carolina

  • Lillestol Research

    Fargo, North Dakota

  • PriMED Clinical Research

    Dayton, Ohio

  • Tribe Clinical Research, LLC

    Greenville, South Carolina

  • WR-Clinsearch, LLC

    Chattanooga, Tennessee

  • Headlands Horizons LLC

    Brownsville, Texas

  • Next Level Urgent Care

    Houston, Texas

  • Houston Research Institute

    Houston, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Chrysalis Clinical Research

    St. George, Utah

  • Charlottesville Medical Research

    Charlottesville, Virginia

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.